language_icon
EN
HI

Orchid Pharma Share price

ORCHPHARMA

703.45

21.40 (3.14%)
NSE
BSE
Last updated on 8 May, 2026 | 15:59 IST
Today's High

706.00

Today's Low

674.55

52 Week Low

480.00

52 Week High

899.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Orchid Pharma Chart

Orchid Pharma Share Key Metrics

Volume
88814.00
Market Cap
3567.84 CR
LTQ@LTP
3@703.45
ATP
694.61
Var Margin
21.81 %
Circuit Range
545.65-818.45
Delivery %
48.81 %
Value
6.17 CR
ASM/GSM
No
Market Lot
1

Summary

Orchid Pharma share price stands at ₹703.45 at 8 May, 2026 | 15:59. The stock Orchid Pharma intraday movement has stayed between ₹674.55 and ₹706.00, while on a 52-week basis it has fluctuated from ₹480.00 to ₹899.00.
In terms of trading activity, Orchid Pharma has recorded a volume of 88814 shares. The Orchid Pharma has a market cap of ₹50719105. The stock’s Average Traded Price (ATP) stands at ₹69461, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3, 70345.
The Orchid Pharma operates within a circuit range of ₹545.65-818.45 – ₹545.65-818.45, with a Value of ₹6.17 CR. The Delivery Percentage for the day is 48.81%. Additionally, Orchid Pharma currently falls under the No framework, and trades with a market lot size of 1.

Orchid Pharma Fundamentals

View More
P/E Ratio

183.18

P/B Ratio

2.74

Div. Yield

0

Sector P/E

68.14

Sector P/B

3.54

Sec. Div. Yield

0.56

Orchid Pharma Resistance and Support

Pivot 678.98

Resistance

First Resistance

697.96

Second Resistance

713.88

Third Resistance

732.86

Support

First Support

663.06

Second Support

644.08

Third Support

628.16

Orchid Pharma Shareholding Pattern

View More
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
  • 2018-19
Total Promoters
Segment
Percent

Total Promoters

26.68%

Mutual Fund

0%

Insurance

3.66%

Foreign Institutional Investors

0.8%

Domestic Institutional Investors

0.06%

Retail

68.8%

Others

0%

Total Promoters
MAR '18
26.69%
JUN '18
26.68%
SEP '18
26.68%
DEC '18
26.68%

Orchid Pharma Corporate Actions

DateAgenda
2026-02-11Quarterly Results
2025-11-11Quarterly Results
2025-08-12Quarterly Results
2025-05-26Audited Results
2025-02-12Quarterly Results

Orchid Pharma News

Orchid Pharma Ltd - 524372 - Intimation Under Regulation 30

NCLT Chennai Bench dismissed DBS Bank's interim application against Orchid Pharma claiming lease rent during the CIRP period. This removes a potential financial liability for the company.
Apr 11 2026 17:04:00

Orchid Pharma Limited

NCLT Chennai Bench dismissed DBS Bank's application against Orchid Pharma regarding lease rent claims during the CIRP period. This order, dated April 2, 2026, confirmed no financial impact on the company.
Apr 11 2026 17:04:00

About Orchid Pharma

NSE : 926  
BSE : 524372  
ISIN : INE191A01027  

Orchid Chemicals & Pharmaceuticals Limited (ORCHID) as incorporated as a Public Limited Company on July 01 1992 under the Companies Act 1956. The Company obtained Certificate of Commencement of Business on October 15 1992. ORCHID has its registered office at Madras ORCHID hasset up a 100% Export Oriented Unit for the manufacture of 7 ADCA (intermediate) Cephalexin Cefradine and Cefadroxyl bulk drugs at a cost of Rs.1195 lakhs in technical and financial collaboration with Sintofarm SPA Italy. This unit is located at SIDCO Pharmaceutical Zone Alathur Tamilnadu. The Project was completed two months ahead ofschedule and after successful trial runs in Jan-94 commercial operations commenced from Feb. 94. In Feb 94 ORCHID undertook a Scheme at a cost of Rs.160 lakhs for better recovery of solvents backward integration and process optimization. During its first two months of operations the Company''s unit achieved a capacity utilization of 80% and produced 12.1 tonnes of Cephalexin out of which 11.7 tonnes (97%) was exported.The products are exported to Germany Italy Switzerland Holland Spain Cyprus Hongkong Singapore etc. and have been well received in the International Markets resulting in repeat orders.

Read More

Orchid Pharma Management

NamePosition
Ram Gopal AgarwalChairman
Manish DhanukaManaging Director
View More

Orchid Pharma FAQs

The Buying Price of Orchid Pharma share is 703.45 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Orchid Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Orchid Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Orchid Pharma shares is 183.18. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Orchid Pharma shares is 2.74. Useful to assess the stock's value relative to its book value.

To assess Orchid Pharma’s valuation compare Sector P/E, P/B which are 68.14 & 3.54 with sector averages, along with growth rates and financial metrics.

The Market Cap of Orchid Pharma is 3567.84 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Orchid Pharma share price is 899.00 & 480.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Orchid Pharma belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost